1. Enjyoji, K. et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Med. 5, 1010–1017 (1999).
2. Burnstock, G. Hypoxia, endothelium and purines. Drug Develop. Res. 28, 301–305 (1993).
3. Ralevic, V. in Cardiovascular Biology of Purines (eds. Burnstock,G., Dobson, J.G., Liang, B.T. & Linden, J.) 206–224 (Kluwer Academic Publisher, London, 1998).
4. Kunapuli, S.P. Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharm. Sci. 19, 391– 394 (1998).
5. Zimmermann, H. & Pearson, J. in Cardiovascular Biology of Purines (eds. Burnstock, G., Dobson, J.G., Liang, B.T. & Linden, J.) 342–358 (Kluwer Academic Publisher, London, 1998).